Nymox Pharmaceutical Corporation

Nymox Pharmaceutical Corporationverified

NYMXF

Price:

$0.052

Market Cap:

$4.92M

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which is in various clinical trials for the treatment of benign prostatic hyperplasia and low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert for detecting tobacco product usage; and TobacAlert for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment of Alzheimer's disease. Nymox Pharmaceutical Corporation was...[Read more]

Industry

Biotechnology

IPO Date

1997-12-22

Stock Exchange

OTC

Ticker

NYMXF

The ROE as of December 2025 (TTM) for Nymox Pharmaceutical Corporation (NYMXF) is 24.07%

According to Nymox Pharmaceutical Corporation’s latest financial reports and current stock price. The company's current ROE is 24.07%. This represents a change of -60.84% compared to the average of 61.47% of the last 4 quarters.

Nymox Pharmaceutical Corporation (NYMXF) Historical ROE (quarterly & annually)

How has NYMXF ROE performed in the past?

The mean historical ROE of Nymox Pharmaceutical Corporation over the last ten years is -705.40%. The current 24.07% ROE has changed -103.41% with respect to the historical average. Over the past ten years (40 quarters), NYMXF's ROE was at its highest in in the December 2022 quarter at 277.80%. The ROE was at its lowest in in the December 2021 quarter at -3385.54%.

Quarterly (TTM)
Annual

Average

-705.40%

Median

66.30%

Minimum

-15104.82%

Maximum

5.42%

Nymox Pharmaceutical Corporation (NYMXF) ROE by Quarter and Year

Discovering the peaks and valleys of Nymox Pharmaceutical Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.42%

Maximum Annual ROE = 5.42%

Minimum Annual Increase = -109.03%

Minimum Annual ROE = -15104.82%

Quarterly (TTM)
Annual
YearROEChange
202466.30%-76.21%
2023278.73%-79.57%
20221.36%-109.03%
2021-15104.82%3.42%
2020-429.33%31.68%
2019-326.03%142.20%
2018-134.61%-105.34%
20172.52%-53.49%

Nymox Pharmaceutical Corporation (NYMXF) Average ROE

How has NYMXF ROE performed in the past?

The current ROE of Nymox Pharmaceutical Corporation (NYMXF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

569.78%

5-year avg

-2764.96%

10-year avg

-705.40%

Nymox Pharmaceutical Corporation (NYMXF) ROE vs. Peers

How is NYMXF’s ROE compared to its peers?

Nymox Pharmaceutical Corporation’s ROE is less than Hemostemix Inc. (68.24%), greater than HOOKIPA Pharma Inc. (-120.60%), greater than Devonian Health Group Inc. (-33.54%), greater than Algorae Pharmaceuticals Limited (-61.85%), less than EOM Pharmaceuticals Holdings, Inc. (59.97%), less than Sirona Biochem Corp. (221.45%), greater than Inhibitor Therapeutics, Inc. (-337.95%), greater than Oxford BioDynamics Plc (-244.86%), less than ALR Technologies Inc. (51.64%), less than Valeo Pharma Inc. (95.58%),

Build a custom stock screener for Nymox Pharmaceutical Corporation (NYMXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nymox Pharmaceutical Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nymox Pharmaceutical Corporation (NYMXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nymox Pharmaceutical Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Nymox Pharmaceutical Corporation's ROE?

How is the ROE calculated for Nymox Pharmaceutical Corporation (NYMXF)?

What is the highest ROE for Nymox Pharmaceutical Corporation (NYMXF)?

What is the 3-year average ROE for Nymox Pharmaceutical Corporation (NYMXF)?

What is the 5-year average ROE for Nymox Pharmaceutical Corporation (NYMXF)?

How does the current ROE for Nymox Pharmaceutical Corporation (NYMXF) compare to its historical average?